Back
Stellantis NV Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
13
STLA
Stellantis NV
Last Price:
$9.23
Seasonality Move:
-4.76%
Sell
28
CRSP
CRISPR Therapeutics AG
Last Price:
$37.79
Seasonality Move:
26.86%
Sell
13
Stellantis NV (STLA)
is a Sell
Is Stellantis NV a Buy, Sell or Hold?
-
The current Stellantis NV [STLA] share price is $9.36. The Score for STLA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
STLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $38.95. The Score for CRSP is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
STLA Stock Price Chart
What is Stellantis NV's stock price today?
-
The Stellantis NV share price today is $9.36Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and STLA is experiencing slight selling pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $38.95Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing slight selling pressure.
STLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.92 | Sell |
Relative Strength Index (14 RSI): | 37.3 | Sell |
Chaikin Money Flow: | -9984828 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.69 - 12.41) | Sell |
Bollinger Bands (100): | (11.4 - 13.78) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.92 | Buy |
Relative Strength Index (14 RSI): | 52.75 | Buy |
Chaikin Money Flow: | -359537 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.11 - 41.89) | Buy |
Bollinger Bands (100): | (37.77 - 47.57) | Sell |
STLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.27 | Buy |
20-day SMA: | 10.73 | Sell |
50-day SMA: | 12.09 | Sell |
200-day SMA: | 14.28 | Sell |
8-day EMA: | 9.52 | Sell |
20-day EMA: | 10.43 | Sell |
50-day EMA: | 11.59 | Sell |
200-day EMA: | 14.41 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 35.31 | Buy |
20-day SMA: | 36.93 | Buy |
50-day SMA: | 41.02 | Sell |
200-day SMA: | 46.39 | Sell |
8-day EMA: | 36.31 | Buy |
20-day EMA: | 30.77 | Buy |
50-day EMA: | 19.36 | Buy |
200-day EMA: | 6.33 | Buy |
Stellantis NV Earnings Growth & STLA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $1.10 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.01 per share, an increase this year of $0.26 per share, and an increase next year of $0.91 per share.
Stellantis NV Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 14 | Apr 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |